Editorial: risky business. What do sufferers' perceptions of risk from interventions for IBS really mean? Authors' reply

Vivek C Goodoory^{1

2}, Cho Ee Ng³, Christopher J Black^{1

2}, Alexander C Ford^{1

2}

Affiliations

¹ Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
² Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
³ County Durham and Darlington NHS Foundation Trust, Durham, UK.

Comment

Vivek C Goodoory et al. Aliment Pharmacol Ther. 2022 May.

. 2022 May;55(9):1220-1221.

doi: 10.1111/apt.16917.

Vivek C Goodoory^{1

2}, Cho Ee Ng³, Christopher J Black^{1

2}, Alexander C Ford^{1

2}

¹ Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
² Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
³ County Durham and Darlington NHS Foundation Trust, Durham, UK.

No abstract available

Comment on

Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome.
Goodoory VC, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Aliment Pharmacol Ther. 2022 May;55(10):1311-1319. doi: 10.1111/apt.16816. Epub 2022 Feb 15. Aliment Pharmacol Ther. 2022. PMID: 35166374 Free PMC article.

1. Goodoory VC, Ng CE, Black CJ, Ford AC. Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome. Aliment Pharmacol Ther. 2022. https://doi.org/10.1111/apt.16816
1. Quigley EM. Editorial: risky business. What do sufferers' perceptions of risk from interventions for IBS really mean? Aliment Pharmacol Ther. 2022;55:1218-9.
1. Black CJ, Yiannakou Y, Houghton LA, Ford AC. Epidemiological, clinical, and psychological characteristics of individuals with self-reported irritable bowel syndrome based on the Rome IV vs Rome III criteria. Clin Gastroenterol Hepatol. 2020;18(2):392-8 e2.
1. Goodoory VC, Yiannakou Y, Houghton LA, Black CJ, Ford AC. Natural history and disease impact of Rome IV versus Rome III irritable bowel syndrome: a longitudinal follow-up study. Clin Gastroenterol Hepatol. 2021. https://doi.org/10.1016/j.cgh.2021.04.043
1. Shivaji UN, Ford AC. Beliefs about management of irritable bowel syndrome in primary care: cross-sectional survey in one locality. Prim Health Care Res Dev. 2015;16(3):263-9.